The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells ex vivo but fails to prevent leukemia development in a murine model

• Marina Wierz,
• Sandrine Pierson,
• Nora Chouha,
• Laurent Désaubry,
• Jean-Hugues François,
• Guy Berchem,
• Jerome Paggetti,
• Etienne Moussay

Affiliations

Marina Wierz

Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg

Sandrine Pierson

Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg

Nora Chouha

Laboratory of Therapeutic Innovation (UMR 7200) CNRS/Université de Strasbourg, Faculté de Pharmacie, Illkirch, Luxembourg

Laurent Désaubry

Laboratory of Therapeutic Innovation (UMR 7200) CNRS/Université de Strasbourg, Faculté de Pharmacie, Illkirch, Luxembourg

Jean-Hugues François

Centre Hospitalier de Luxembourg, Luxembourg

Guy Berchem

Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg;Centre Hospitalier de Luxembourg, Luxembourg

Jerome Paggetti

Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg

Etienne Moussay

Laboratory of Experimental Cancer Research, Department of Oncology, Luxembourg Institute of Health, Luxembourg